Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-01 Sale | 2026-06-02 5:35 pm | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 3,200 | $9.45 | $30,240 | 21,216 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 5:31 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 379 | $9.45 | $3,582 | 61,902 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 12:35 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $10.05 | $221,025 | 1,078,391 (Direct) | View |
| 2026-04-06 Sale | 2026-04-07 4:50 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne President and CEO | 72,559 | $9.156 | $664,350 | 1,001,263 (Indirect Direct) | View |
| 2026-04-01 Sale | 2026-04-02 10:46 am | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $9.0735 | $199,617 | 1,100,391 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 4:35 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 7,711 | $9.12 | $70,324 | 61,902 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 12:10 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $9.5082 | $209,181 | 1,122,391 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:56 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 42,377 | $9.7545 | $413,366 | 1,144,391 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:56 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,430 | $9.5326 | $13,632 | 69,613 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:55 pm | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 1,634 | $9.5326 | $15,576 | 162,615 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:55 pm | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 3,505 | $9.6875 | $33,955 | 154,024 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:54 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP, General Counsel, Corp Sec | 16,817 | $9.7667 | $164,247 | 112,982 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:54 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 14,762 | $9.5326 | $140,720 | 1,073,822 (Indirect Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:13 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,829 | $7.4528 | $13,631 | 121,043 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:12 pm | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 2,089 | $7.4528 | $15,569 | 274,249 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:11 pm | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 2,089 | $7.4528 | $15,569 | 267,529 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:10 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP, General Counsel, Corp Sec | 4,445 | $7.4528 | $33,128 | 239,799 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:09 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 19,039 | $7.4528 | $141,894 | 1,658,584 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-18 3:38 pm | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 1,530 | $7.79 | $11,919 | 47,872 (Direct) | View |
| 2026-02-02 Sale | 2026-02-03 12:28 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $7.7123 | $169,671 | 1,144,391 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 1:57 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $5.9265 | $130,383 | 1,166,391 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 191,854 | $5.9826 | $1,147,786 | 13,728,924 (Indirect) | View |
| 2025-12-01 Sale | 2025-12-02 7:48 pm | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $6.0032 | $132,070 | 1,188,391 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 189,431 | $6.4069 | $1,213,667 | 13,920,778 (Indirect) | View |
| 2025-11-24 Sale | 2025-11-26 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 463,774 | $6.2666 | $2,906,278 | 14,110,209 (Indirect) | View |
| 2025-11-17 Sale | 2025-11-18 2:47 pm | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 6,799 | $5.557 | $37,782 | 110,701 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 3:27 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP, General Counsel, Corp Sec | 2,385 | $5.16 | $12,307 | 78,210 (Direct) | View |
| 2025-11-03 Sale | 2025-11-04 7:40 pm | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel | 1,365 | $5.863 | $8,003 | 80,595 (Direct) | View |
| 2025-11-03 Sale | 2025-11-04 11:58 am | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 22,000 | $5.6385 | $124,047 | 1,210,391 (Direct) | View |
| 2025-10-28 Sale | 2025-10-30 4:30 pm | Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SOFTBANK VISION FUND (AIV M1) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 24,553 | $6.5024 | $159,655 | 14,573,983 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-09 Option Award | 2026-06-10 6:21 pm | N/A 2036-06-08 | Vir Biotechnology Inc. | VIR | Coughlin Timothy Director | 40,000 | $0 | 48,000 (Direct) | View |
Ownership | 2026-06-10 6:20 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Coughlin Timothy Director | 0 | $0 | 0 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:25 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 24,000 | $0 | 65,806 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:25 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | Napolitano Janet Director | 24,000 | $0 | 40,416 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:25 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | MORE ROBERT J Director | 24,000 | $0 | 574,573 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:24 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director | 24,000 | $0 | 55,806 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:24 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | Farid Ramy Director | 24,000 | $0 | 48,000 (Direct) | View |
| 2026-05-27 Option Award | 2026-05-28 7:23 pm | 2027-05-27 2036-05-26 | Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director | 24,000 | $0 | 48,000 (Direct) | View |
| 2026-04-29 Other | 2026-04-30 5:43 pm | N/A N/A | Vir Biotechnology Inc. | VIR | De Backer Marianne President and CEO | 233,532 | $0 | 1,468,327 (Direct) | View |
| 2026-03-20 Other | 2026-03-23 3:49 pm | N/A N/A | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 2,500 | $0 | 167,615 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:56 pm | N/A 2027-10-05 | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 42,377 | $0 | 1,144,391 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:56 pm | N/A N/A | Vir Biotechnology Inc. | VIR | SATO VICKI L Director | 42,377 | $1.485 | 1,144,391 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:13 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer | 75,000 | $0 | 121,043 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:12 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer | 165,000 | $0 | 274,249 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:11 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer | 165,000 | $0 | 267,529 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:10 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP, General Counsel, Corp Sec | 165,000 | $0 | 239,799 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:09 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 855,000 | $0 | 1,658,584 (Direct) | View |